GSA Capital Partners LLP Acquires New Shares in Agilent Technologies, Inc. (NYSE:A)

GSA Capital Partners LLP acquired a new stake in Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 3,363 shares of the medical research company’s stock, valued at approximately $499,000.

Several other large investors have also bought and sold shares of A. Covestor Ltd boosted its stake in shares of Agilent Technologies by 231.5% during the first quarter. Covestor Ltd now owns 494 shares of the medical research company’s stock valued at $72,000 after purchasing an additional 345 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its stake in shares of Agilent Technologies by 33.0% during the first quarter. O Shaughnessy Asset Management LLC now owns 22,326 shares of the medical research company’s stock valued at $3,249,000 after purchasing an additional 5,538 shares in the last quarter. Lake Street Advisors Group LLC boosted its stake in shares of Agilent Technologies by 102.9% during the first quarter. Lake Street Advisors Group LLC now owns 3,174 shares of the medical research company’s stock valued at $462,000 after purchasing an additional 1,610 shares in the last quarter. Pitcairn Co. boosted its stake in shares of Agilent Technologies by 3.0% during the first quarter. Pitcairn Co. now owns 6,220 shares of the medical research company’s stock valued at $905,000 after purchasing an additional 184 shares in the last quarter. Finally, Natixis boosted its stake in shares of Agilent Technologies by 27.0% during the first quarter. Natixis now owns 54,782 shares of the medical research company’s stock valued at $7,971,000 after purchasing an additional 11,646 shares in the last quarter.

Analysts Set New Price Targets

A has been the topic of a number of recent research reports. TD Cowen lifted their price target on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Citigroup raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Wells Fargo & Company assumed coverage on Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price objective for the company. Stifel Nicolaus restated a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Finally, Evercore ISI raised their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Trading Down 1.0 %

NYSE A opened at $125.70 on Wednesday. The company has a market cap of $36.12 billion, a price-to-earnings ratio of 26.08, a P/E/G ratio of 5.59 and a beta of 1.07. Agilent Technologies, Inc. has a 52 week low of $112.39 and a 52 week high of $155.35. The business has a 50 day moving average price of $138.26 and a 200-day moving average price of $137.83. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company’s quarterly revenue was down 5.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.43 earnings per share. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a dividend of $0.236 per share. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 annualized dividend and a dividend yield of 0.75%. Agilent Technologies’s dividend payout ratio is 19.50%.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. The trade was a 7.51 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,995 shares of company stock worth $1,739,510 over the last quarter.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.